CGS 22652: A New Potent Thromboxane A2 Receptor Antagonist with Selective Thromboxane A2 Synthase Inhibitory Properties
- 1 December 1992
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 10 (4) , 379-391
- https://doi.org/10.1111/j.1527-3466.1992.tb00257.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysisJournal of the American College of Cardiology, 1989
- Studies In The Guinea-pig With ICI 185,282: A Thromboxane A2 Receptor AntagonistJournal of Pharmacy and Pharmacology, 1988
- Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.Journal of Clinical Investigation, 1987
- Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysisAmerican Heart Journal, 1987
- Thromboembolism and antithrombotic therapy in cerebrovascular diseaseJournal of the American College of Cardiology, 1986
- The biochemical pharmacology of thromboxane synthase inhibition in man.Circulation, 1985
- Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosisInternational Journal of Cardiology, 1984
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980